Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma (Q21135231)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma |
scientific article |
Statements
Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma (English)
0 references
Arun George Paul
Neelam Sharma-Walia
Bala Chandran
2011
0 references
6
0 references
e24379
0 references
9
0 references
30 September 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference